Low treatmentadherence

Poor adherence to treatments has been associated with an increase number of patients with multi-chronic diseases. These parallels have contributed to compromised patient outcomes and an increase in healthcare costs. Improving treatment adherence is becoming a key priority for healthcare actors to balance the cost of our healthcare systems.

lorem ipsum

Global economic pressure on pharma sector

Pharma companies have to cope with governments pressure to contain healthcare expenditure. In Europe, growth rates are declining and valued at 1-4% over the next 5 years in comparison to previous years which was 5%. In this context, efficiency, profitability, and innovative approaches are necessary to safeguard sustainable growth in the industry.

lorem ipsum

Generic drugscompetition

90% of the current Top 20 world drugs will compete against a generic or biosimilar drug by 2023. The loss of revenues is estimated at nearly $120 billion in developed country markets (2019-2023). Shortening the period of active promotion of Rx products requires offensive and efficient commercial strategies.

lorem ipsum

Beyond the pillapproach

Governments, patients and HCP’s all expect pharma companies to bring added value support for health products, which implies offering a full range of services throughout the product life cycle. Added value services such as Patients Support Programs are the new excepted model: scientific projects with MSLs, web conferences with KOLs, mobile apps for healthcare practitioners and patients, drug delivery, patient support programs etc.

lorem ipsum

Why we are the perfect match

Our Efficiency

Relying on Consultants, Pharmacists & Doctors, Nurses & Certified Medical Reps, we have a long-standing experience in supporting our customers in their evolving markets.

Our Quality

More than 100 pharma companies, hospitals, insurance companies trust our ability to help them to face their new challenges: increasing the digital share in promotion, facing competition from generic players and developing innovative services.

Our Innovation

Innovation is part of our DNA. Pioneer in direct sales, hybrid promotion and patients support programs, we aim at designing new healthcare models. Our track-record for innovation is enhanced with 20 years of valuable behavioural data collected from French pharmicists and doctors. This has enabled us to create fully customizable proprietary tools and a hybrid approach for their preferences.

Why we are the perfect match

Relying on Consultants, Pharmacists & Doctors, Nurses & Certified Medical Reps, we have a long-standing experience in supporting our customers in their evolving markets.

More than 100 pharma companies, hospitals, insurance companies trust our ability to help them to face their new challenges: increasing the digital share in promotion, facing competition from generic players and developing innovative services.

Innovation is part of our DNA. Pioneer in direct sales, hybrid promotion and patients support programs, we aim at designing new healthcare models. Our track-record for innovation is enhanced with 20 years of valuable behavioural data collected from French pharmicists and doctors. This has enabled us to create fully customizable proprietary tools and a hybrid approach for their preferences.

Our solutions to support you

Let's talkabout you!

Contact us

Hello,Ready to start the conversation!

Texte alternatif

Let's talkabout you!

Contact us

Client stories

Client stories

Latest news about Healthcare

Latest news about Healthcare